Real-time enrollment status for this chronic leukemia myelogenous clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 1:37 AM UTC
| NCT Number | NCT06297161 |
| Recruiting Status | Recruiting |
| Condition | Chronic Leukemia Myelogenous |
| Phase | Clinical Trial |
| Target Enrollment | 600 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | April 14, 2026 (Apr 14, 2026) |
As of July 19, 2026: Clinical trial NCT06297161 is currently recruiting participants. This clinical trial study for chronic leukemia myelogenous is actively seeking new participants at 1 location across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06297161 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06297161 was last updated Apr 14, 2026 (April 14, 2026). HelloStudys verifies this status automatically.